Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$29.38 +0.89 (+3.12%)
At close: Nov 9, 2026 · 4:00 PM EST

Amphastar Pharmaceuticals (AMPH) Return on Sales [ROS] (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) reported Return on Sales [ROS] of 21.60% for Q2 2026, down 2.58 percentage points from 24.19% a year earlier but up 13.64 percentage points from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Return on Sales [ROS] (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Amphastar Pharmaceuticals' Return on Sales [ROS] came in at 15.66%, down 9.48 percentage points year-over-year; for FY2025, it was 19.50%, down 8.56 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of +16.37 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at 28.06% in FY2024 (-2.51 pp), 30.57% in FY2023 (+9.03 pp), 21.54% in FY2022 (+5.58 pp) and 15.96% in FY2021 (+12.83 pp).
  • Five-year quarterly Return on Sales [ROS] spans a low of 7.96% in Q1 2026 and a high of 40.25% in Q3 2023.
  • Year over year, Return on Sales [ROS] has now declined in each of the last eight quarters, with an average year-over-year change of -8.32 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q3 2023 (a gain of 20.92 percentage points); the low point was Q3 2025 (a drop of 16.64 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 7.96% (Q1 2026), 19.45% (Q4 2025) and 13.20% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 24.35%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 36.01%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 30.89%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 29.12%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 35.79%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 41.71%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 32.98%
10 Amphastar Pharmaceuticals 1.25 Bn 156.30 Mn 99.63 Mn 24.46%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 24.46%
Jun 30, 2026 21.60%
Mar 31, 2026 7.96%
Dec 31, 2025 19.45%
Sep 30, 2025 13.20%
Jun 30, 2025 24.19%
Mar 31, 2025 21.87%
Dec 31, 2024 24.20%
Sep 30, 2024 29.83%
Jun 30, 2024 30.27%
Mar 31, 2024 27.94%
Dec 31, 2023 30.31%
Sep 30, 2023 40.25%
Jun 30, 2023 25.32%
Mar 31, 2023 23.88%
Dec 31, 2022 28.02%
Sep 30, 2022 19.34%
Jun 30, 2022 20.10%
Mar 31, 2022 17.96%
Dec 31, 2021 20.06%
API Access

Amphastar Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AMPH&period=max&api_key=YOUR_API_KEY